| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V51559 | 8-Hydroxy-efavirenz | 205754-33-2 | major metabolite of Efavirenz |
|
V2665 | BI-78D3 | 883065-90-5 | BI-78D3 (also known as JNK Inhibitor X) is a novel, potent and competitive JNK inhibitor with IC50 of 280nM. |
|
V2078 | CC-401 | 395104-30-0 | CC-401 (CC401) is a potent, specific, 2nd generation and ATP-competitive anthrapyrazolone c-Jun N terminal kinase (JNK) inhibitor with potential antineoplastic activity. |
|
V2978 | CC-401 HCl | 1438391-30-0 | CC-401 HCl (CC401 hydrochloride) is an anthrapyrazolone-based inhibitor of c-Jun N terminal kinase (JNK) with potential anticancer activity. |
|
V2263 | CC-90001 | 1403859-14-2 | CC-90001 (CC90001; CC 90001) is a novel, potent and selective inhibitor of c-Jun N-terminal kinase (JNK) with potential anti-fibrotic activity. |
|
V87071 | CMX-8933 | 146877-90-9 | CMX-8933 is an octapeptide fragment of the goldfish brain neurotrophic factor ependymin. |
|
V137776 | ICA-1S | ICA-1S is a specific PKC-1 inhibitor. | |
|
V51553 | JIP-1 (153-163) | 438567-88-5 | peptide-based JNK inhibitor |
|
V87072 | JIP-1(153-163) TFA | JIP-1(153-163) TFA (TI-JIP TFA) is a peptide inhibitor of c-JNK. | |
|
V85683 | JNK-IN-15, Cell-Permeable, Negative Control | ||
|
V138271 | JNK1 degrader-1 | JNK1 degrader-1 is a JNK1 HyT degrader. | |
|
V0473 | TCS JNK 5a | 312917-14-9 | TCS JNK 5a (alsoknown asJNK Inhibitor IX; TCS JNK-5a) is a novel, highly selective and potent JNK (c-Jun N-terminal Kinase) inhibitor with potential antineoplastic activity. |
|
V0472 | JNK-IN-8 | 1410880-22-6 | JNK-IN-8 (JNK Inhibitor XVI; JNK-IN8) is the first irreversible/covalent inhibitor of pan-JNK (c-Jun N-terminal Kinase) with potential antitumor activity. |
|
V74394 | n-Butyl α-D-fructofuranoside | 80971-59-1 | n-Butyl α-D-fructofuranoside is extracted from the root bark of Ulmus davidiana var. |
|
V144257 | Ro 31-8220 formic | Ro 31-8220 formic is a potent PKC inhibitor with IC50 values of 5, 24, 14, 27, 24, and 23 nM for PKCα, PKCβI, PKCβII, PKCγ, PKCε, and rat brain PKC, respectively. | |
|
V144578 | Saquinavir-13C6 | Saquinavir-13C6 is 13C-labeled saquinavir. | |
|
V1565 | Tanzisertib (CC-930) | 899805-25-5 | Tanzisertib (formerly known as CC-930,JNK-930, JNKI-1,CC 930) is a potent, specific andand orally bioavailable JNK1/JNK2/JNK3 inhibitor that has the potential to be used for the treatment of fibrotic and infammatory indications. |
|
V147130 | Wnt/β-catenin-IN-6 | Wnt/β-catenin-IN-6 is an orally effective inhibitor of the Wnt/β-catenin pathway. | |
|
V147549 | α-Neoendorphin (porcine) | 77739-20-9 | α-Neoendorphin (porcine) is a peptide. |
|
V0471 | SP600125 (SP600125; NSC75890) | 129-56-6 | SP600125 (SP6-00125; NSC-75890) is a cell-permeable, broad-spectrum, reversible and ATP-competitive JNK (c-Jun N-terminal Kinase) inhibitor with potential anticancer and anti-inflammatory activity. |